Enara Health Review
Best for: Insured patients in its six states wanting branded GLP-1 plus full obesity-medicine care
Enara Health (enarahealth.com), founded 2015 in San Mateo, CA, is a physician-led, insurance-based obesity medicine program that prescribes branded GLP-1 medications including Wegovy (semaglutide) and Zepbound (tirzepatide), alongside dietitian counseling, health coaching, metabolic testing, and behavioral support. Its prior-authorization service gets brand medications covered for over 65% of members through insurers like UnitedHealthcare, BCBS, Aetna, Cigna, Humana, and Medicare. Enara operates via partner clinics in six states: California, Oregon, Arizona, Maryland, Minnesota, and Kansas.
High confidence · Last verified 2026-06-04 · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Enara Health is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Enara Health prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
✓ Pros
- •Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound) not compounded
- •Insurance-based with prior-auth coverage for over 65% of members
- •Board-certified obesity-medicine physicians
- •Comprehensive program: dietitian, coaching, metabolic and genetic testing
- •Established since 2015 with clinical track record
✗ Cons
- •Available in only six states via partner clinics
- •Requires in-network insurance; not a flat cash-pay option
- •Not a pure-telehealth nationwide service
- •Out-of-pocket cost varies by insurance coverage
- •No compounded budget alternative for the uninsured
Ready to start with Enara Health?
See current pricing and start your free consultation.
Sources & methodology
Our Enara Health review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
Alternatives to Enara Health
Editorial score · methodology
Bodybuilding Health+
Best for: fitness-brand compounded GLP-1 with hormone and performance programs
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Enara Health?
See current pricing and start your free consultation.